ArticleJournal of biophotonics2026
In Vivo Monitoring of Pressure Ulcer Model Development and Recoverability Under Multimodal Parameters Within a Unified Field of View.
Article in Journal of biophotonics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study utilizes an integrated laser speckle (LSCI) and intrinsic optical signal imaging (IOSI) system to evaluate microvascular dynamics in murine pressure ulcer (PU) models. We compared a single prolonged compression (6 h) against repeated compressions (1.5 h/day for 7 days) using an enhanced spatiotemporal gradient analysis of LSCI data. In the repeated compression model, gradient analysis revealed a progressive perfusion decline by Day 4. By Day 7, perfusion gradients indicated near-complete flow loss, corresponding to severe hypoxia detected by IOSI, signifying sustained microvascular impairment. Conversely, the single compression model exhibited reversible alterations; LSCI gradients showed initial disruption followed by gradual recovery, with perfusion nearing baseline by Day 7. The LSCI-IOSI platform, emphasizing advanced gradient processing, systematically delineates microcirculatory compromise. This approach highlights the critical role of repeated ischemia-reperfusion in driving persistent dysfunction and demonstrates the utility of quantitative optical imaging for early detection and targeted intervention in PU progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.